Document text
Principal Investigator: Kelsey H Fisher-Wellman
Organization: EAST CAROLINA UNIVERSITY
Fiscal Year: 2024
Award: $95,115
Funding agency: National Cancer Institute
ABSTRACT
Relative to matched normal tissue, recent large scale sequencing efforts indicate that colorectal cancer (CRC)
tumors are specifically enriched in loss of function mutations in mitochondrial DNA (mtDNA); however, the
significance and functional consequences of high mtDNA mutational burden in CRC remains unknown. Given
that mtDNA encodes critical subunits in 4 out of the 5 complexes of the electron transport chain (ETC), high
mtDNA mutational burden suggests that CRC incidence and/or pathogenesis is dependent on disruptions in
mitochondrial respiration. On the contrary, impairing tumor mitochondrial respiration, via pharmacological ETC
inhibitors or deletion of genes required for the function of the respiratory complexes, blunts tumor growth across
many tumor types, including CRC. Together, these seemingly contradictory data sets highlight an intriguing
paradox: how do accumulated mtDNA mutations support CRC tumorigenesis, if mitochondrial oxidative
metabolism is inherently required for tumors to grow? Generating targeted and efficient CRC therapeutics is
dependent on answering this question. In preliminary studies using purified human CRC mitochondria we
confirmed that, relative to matched normal, CRC tumors have more mtDNA mutations and discovered that
functional bioenergetic deficiencies exclusively localize to mitochondrial complex I, with 100% (12/12) of clinical
CRC tumors displaying partial loss-of-function in complex I activity. To model human CRC bioenergetic
deficiencies in the mouse, we reduced complex I activity by 50% in the colon using tissue-specific deletion of the
complex I accessory subunit NDUFS4. Partial complex I inhibition increased both tumor number and size
following CRC initiation with AOM/DSS and induced a pronounced growth advantage in tumor-derived
organoids. These results demonstrate that partial complex I loss of function provides a growth advantage
sufficient to accelerate CRC outgrowth. Surprisingly, despite it's role as the initiating complex of the ETC,
complex I deficient CRC tumors respired normally; although at the expense of increased matrix NADH/NAD+.
Additional bioenergetic analysis revealed that CRC tumors circumvent NADH/NAD+ hyper-reduction to sustain
mitochondrial oxidative metabolism by uncoupling respiration from ATP synthesis. Thus, our preliminary data
indicate that CRC mitochondria exhibit unique metabolic rewiring that allows respiration to proceed despite
partial complex I inhibition. The goal of this project is to test the hypothesis that partial complex I deficiency
induces increased NADH/NAD+ and/or respiratory uncoupling that accelerates CRC growth. Successful
completion of this project will establish the mechanisms by which complex I deficiency accelerates CRC. Given
that complex I genes are the most frequently mutated mtDNA genes across tumor types, these findings will
provide broader insight on the interplay between mitochondrial function and cancer.
Terms: <ATP Synthesis><ATP Synthesis Pathway><Acceleration><Active Oxygen><Anabolism><Aspartate><Autoregulation><Biochemistry><Bioenergetics><Biological Chemistry><Body Tissues><Cancer Model><CancerModel><Cancers><Catalytic Core><Catalytic Domain><Catalytic Region><Catalytic Site><Catalytic Subunit><Cell Growth in Number><Cell Multiplication><Cell Proliferation><Cell Respiration><Cellular Proliferation><Cellular Respiration><Chemicals><Clinical><Colon><Colorectal Cancer><Complex><Cytochrome c Reductase><Cytosol><Data><Data Set><Electron Transport><Exhibits><Exposure to><GEM model><GEMM model><Gene Deletion><Generalized Growth><Generations><Genes><Genetic><Genetically Engineered Mouse><Glutamates><Goals><Growth><Heterograft><Heterologous Transplantation><Homeostasis><Human><Impairment><In Vitro><Incidence><Intervention><Intervention Strategies><KO mice><Knock-out Mice><Knockout Mice><L-Aspartate><L-Glutamate><Large-Scale Sequencing><Link><Malignant Cell><Malignant Neoplasms><Malignant Tumor><Mediating><Metabolic><Mice><Mice Mammals><Mitochondria><Mitochondrial DNA><Modern Man><Molecular><Murine><Mus><Mutate><NADH><NADH Cytochrome c Oxidoreductase><NADH Cytochrome c Reductase><NADH Dehydrogenase><Normal Tissue><Normal tissue morphology><Null Mouse><Oncogenesis><Organoids><Oxidation-Reduction><Oxygen Radicals><Pathogenesis><Pathogenicity><Pathway interactions><Physiological Homeostasis><Pro-Oxidants><Proteins><Proteome><Reactive Oxygen Species><Redox><Respiration><Respiratory physiology><Role><Stress><Testing><Therapeutic><Tissue Growth><Tissues><Tumor-Derived><Viral Genetics><Work><Xenograft><Xenograft procedure><Xenotransplantation><Yeasts><aerobic metabolism><aerobic respiration><alternative oxidase><antiporter><biosynthesis><burden of disease><burden of illness><cancer cell><cancer initiation><catalase><disease burden><electron transfer><experiment><experimental research><experimental study><experiments><gene deletion mutation><gene manipulation><genetic approach><genetic manipulation><genetic strategy><genetically engineered mouse model><genetically engineered murine model><genetically manipulate><genetically perturb><glutamatergic><human model><in vivo><inhibitor><insight><interventional strategy><loss of function><loss of function mutation><malignancy><mitochondrial><mitochondrial DNA mutation><mitochondrial metabolism><model of human><mouse model><mtDNA><mtDNA mutation><murine model><neoplasm/cancer><ontogeny><oxidation><oxidation reduction reaction><oxidative metabolism><pathway><pharmacologic><respiratory><respiratory function><respiratory mechanism><response><social role><transgene expression><tumor><tumor growth><tumorigenesis><tumorigenic><virus genetics><xeno-transplant><xeno-transplantation>